Your browser doesn't support javascript.
loading
Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.
Nahum, Gerard G; Kaunitz, Andrew M; Rosen, Kimberly; Schmelter, Thomas; Lynen, Richard.
Afiliação
  • Nahum GG; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981-0915, United States. Electronic address: gerard.nahum@bayer.com.
  • Kaunitz AM; University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA.
  • Rosen K; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981-0915, United States.
  • Schmelter T; Bayer Pharma AG, Müllerstr. 178, 13353 Berlin, Germany.
  • Lynen R; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981-0915, United States.
Contraception ; 91(5): 412-7, 2015 May.
Article em En | MEDLINE | ID: mdl-25661510
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cistos Ovarianos / Levanogestrel / Anticoncepção / Anticoncepcionais Femininos / Dispositivos Intrauterinos Medicados Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cistos Ovarianos / Levanogestrel / Anticoncepção / Anticoncepcionais Femininos / Dispositivos Intrauterinos Medicados Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article